Condat Introduces IoT on Tunnel Boring Sites Thanks to delaware and Sigfox
Condat, a global specialist in surface chemistry including industrial lubricants, today announced its partnership with Sigfox, the world's leading IoT service provider and initiator of the 0G network. With its long-term partner delaware, an internationally renowned integrator of innovative technology solutions, the two companies have created CondatLink, an IoT solution capable of helping tunnel boring machine operators to better manage their supply and stock of sealant on construction sites.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005389/en/
A tunnel boring site (Photo: Sigfox)
Sealant stock management: a major challenge for tunnel construction
With more than 25 years of experience in the field of tunnels, with more than 4,500 km laid, Condat has unique know-how and an international reputation in its sector. In particular, the company is a leader in the manufacture and supply of tail seal greases, products designed for tunnel construction in wet areas. Tail seal greases are essential for tunnelling especially in the event of water ingress, as job sites risk being delayed and, in the worst case, may even be submerged.
Condat delivers all over the world using 20-ton containers. Until now Condit’s sales teams worked with customers to estimate requirements, without being able to obtain precise information on sealant consumption.
"We needed a solution to prevent our tunnel boring machine customers from running out of sealant on their sites. In the life of a construction site, many parameters can speed up or slow down the consumption of this product. To satisfy our customers, we had to think of a way to find out about it, without having to contact someone on the worksites. We had the feeling that IoT was the right way to go, so we turned to delaware, our technology solutions partner of more than 23 years, to help us," explains Guy Chemisky, Director of Operations at Condat.
CondatLink started as a concept last November at Del20, the delaware working group focused on innovation, where concrete cases and feedback are shared, and in January, the project was launched:
"We started this project together by working on an end-to-end strategy: from the ideas phase to the design of the applications. We then put several people from the IoT ecosystem in touch with each other. Sigfox was chosen to support us during the implementation of this project and the design of the tracking and monitoring equipment," adds Baptiste Duriez, Partner at delaware.
Sigfox was chosen by Condat for its 0G network covering more than 70 countries and regions and its proposal to fully integrate the solution into Condat's SAP environment.
"We were very delighted by the maturity of the thinking. The Condat and delaware teams had carried out an in-depth study of the service experience expected for users and how the solution would fit into production. Even the notion of return on investment with stock management had been analysed. We were therefore able to bring our expertise to the project to introduce a solution very quickly," says Patrick Cason, Managing Director of Sigfox France.
"This project was carried out thanks to a dozen-strong team from Condat, delaware and Sigfox. By combining all these skills, the spirit of innovating together and the desire to co-develop with our suppliers, we managed to finalize this project in a very short timeframe and in the middle of a period of lockdown," adds Guy Chemisky.
The IoT for better consumption monitoring on construction sites
Sigfox's expertise has led to the implementation of the CondatLink solution, which will be available internationally and will enable more precise information about the level of consumption of sealant on building sites, thanks to a connected device that monitors the opening and closing of sealant drums.
The device is attached to the drums as soon as they leave the production plant. It is small (116x45x30mm), light (around 100g) and has, at least, a one-year battery life. As for the software, it uses Sigfox Monarch (international device, frequency management) and Atlas (geolocation) technologies. It will emit a message regularly to signal the location of the drum (asset tracking) while emitting regular messages indicating its change of state when the drum is opened (asset monitoring).
The information obtained by this connected device is sent to Condat and their clients via the Sigfox 0G network and available on a dedicated tracking application. This platform will take the form of a dashboard allowing the customer to track consumption and stock, and Condat to manage its deliveries worldwide.
Aware of environmental issues, Condat has been offering solutions for more than 20 years that are more respectful of individuals and the planet. The development of CondatLink is part of this approach. Thus, with delaware and Sigfox, Condat wanted to pay particular attention to the ecodesign and optimization of the battery. Moreover, the optimisation of transport and the better planning of deliveries, obtained via this solution, enable the company to avoid air transport as much as possible and, therefore, to greatly reduce carbon footprint.
A first use case that aims to deploy tens of thousands of connected objects
A test phase is planned for July with the implementation of this solution over two sites. Initially, the challenge will be the deployment of tens of thousands of objects by next year.
"Tomorrow, we will be able to go further than just monitoring the consumption of sealant on building sites. It will be possible to do this with many other products and for sectors other than tunnel builders. One of our major technological challenges in the coming years will be to make greater use of the data we have been collecting for more than 20 years to build predictive models and serve our customers better," concludes Guy Chemisky.
Sigfox is the initiator of the 0G network and the world’s leading IoT (Internet of Things) service provider. Its global network allows billions of devices to connect to the Internet, in a straightforward way, while consuming as little energy as possible. Sigfox’s unique approach to device-to-cloud communications addresses the three greatest barriers to global IoT adoption: cost, energy consumption and global scalability.
Today, the network is available in 70+ countries, with 1 billion people covered. ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox empowers companies to move their business model towards more digital services, in key areas such as Asset Tracking and Supply Chain. Founded in 2010 by Ludovic Le Moan and Christophe Fourtet, the company is headquartered in France and has offices in Madrid, Munich, Boston, Dallas, San Jose, Dubai, Singapore, Sao Paulo and Tokyo.
Condat, an independent international group of French origin, formulates and manufactures a complete range of lubricants and special chemicals for the world of industry.
With proven technical and sales expertise over 160 years, the CONDAT group offers one of the widest ranges on the market, and knows how to satisfy the requirements of many fields of application: wire drawing, tunnel boring, forging, glass, machining, industrial maintenance...
CONDAT recommends to its customers the best lubrication solution from a technical and economical point of view, while taking into account environmental and safety issues.
Leader in tunnelling:
Since 1989, Condat has been developing a complete range of products, lubricants and additives meeting the technical, safety and environmental requirements of underground works such as : tails seal greases, main bearing tail seal greases, hydraulic fluids, foaming agents and polymers, additives for ground treatment... CONDAT, worldwide leader on this application, offers a complete range of biodegradable and fire resistant products dedicated to this market. With the support of a dedicated team of experts and complete services (training, advice...), CONDAT does its utmost to support tunnel specialists whatever the type of tunnel boring machine and the constraints of the construction site.
delaware is a global company that delivers advanced ICT solutions and services, recognized on the French market and internationally, delaware helps companies in the daily use of their information system, thanks to its 350 experts based in Lyon, Lille, Nantes, Paris, and Bordeaux. delaware is an internationally renowned company, present in 12 countries with 24 offices.
delaware guides its clients throughout the transformation of their business by relying on its local agencies and deploying the solutions of its main business partners SAP & Microsoft.
Business transformation, next-gen applications, customer connection, data and analysis, applied innovations, information management, maintenance, training: delaware supports its customers in their digital transformation thanks to the most innovative technologies (next-gen erp, artificial intelligence, blockchain, cloud, intelligent applications, IoT, virtual and augmented reality, chatbot, etc.), particularly in the retail, food and beverage, automotive, engineering and professional services industries.
Antoine Mège, PR & Content Manager
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sensorion successfully raises approximately €31 (US$ 36.5) million in an oversubscribed private placement to US and European investors18.9.2020 08:00:00 CEST | Press release
Regulatory News: Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This press release is not intended as an offer and is for informational purpose only Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN – the “Company”) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders announces today the success of its previously announced capital increase. The Company has placed 18,236,000 new ordinary shares with a nominal value of €0.10 each (the “New Shares”), for total gross proceeds of approximately € 31 million by means of an accelerated bookbuild offering to the benefit of categories of persons (the “Reserved Offering”). The issue price of the New Shares is €1.70 per share, representing a 3.5% discount to the weighted average share price on the day preceding the date on which the issuance price
Vifor Pharma Group Announces Successful Sale of OM Pharma18.9.2020 07:00:00 CEST | Press release
Regulatory News: Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal include: A purchase consideration of MCHF 435 for 100% of the share capital An earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity to be determined before the end of 2027 upon a trade sale, IPO or EBITDA multiple This earn out together with the purchase consideration could result in a total transaction value exceeding MCHF 500. The deal is expected to close within 30 days. OM Pharma is a Geneva-based company mainly active in the field of microbial derived immunotherapeutics and has developed strongly outside the core strategy of Vifor Pharma over the past few years. Optimus Holding Ltd. is a Swiss Group, founded by Etienne Jornod together with long-standing Swiss entrepreneurs and Abdi Ibrahim (28.5%), a Turkey-based pharmaceutical company operating in 12 countries a
ESMO 2020: Phase II CLARINET FORTE Results Show Increasing Dose Frequencies of Somatuline ® Autogel ® (lanreotide) Allows Patients with NETs to Delay Treatment Escalation by up to 8.3 Months18.9.2020 07:00:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the release of first efficacy and safety data from the CLARINET FORTE study, with the abstract to be presented as a mini-oral presentation at the 2020 European Society for Medical Oncology (ESMO) Congress, taking place virtually from 19-21 September 2020. The prospective single-arm, open-label, exploratory, international Phase II study investigated the efficacy and safety of increasing the dose frequency of Somatuline® Autogel®(lanreotide) in patients with pancreatic or midgut NETs with centrally-assessed progression within the last two years while on a standard lanreotide regimen for ≥24 weeks. An extension of progression-free survival (PFS) rates and encouraging disease-control rates (DCR) were recorded in both tumor types, with no new safety signals. “These results support a clinically meaningful benefit to a population of patients with high unmet medical need by potentially delaying escalation to more toxic treatmen
A Continuous Journey of Digital Transformation, Alibaba Cloud and Its Global Customers at Apsara 202018.9.2020 05:00:00 CEST | Press release
As the digital technology and intelligence backbone of Alibaba Group, Alibaba Cloud is experiencing continuous growth alongside its customers across different parts of the world. Over the years, it has made relentless efforts to serve clients from every industry, helping them accelerate their business development and navigate the challenges of these volatile times. Cloud computing and AI technology have been shown to be the cornerstone for businesses seeking to be fully equipped in the digital era, especially following the global outbreak of COVID-19. At the 12th Apsara Conference: Leap into the Future of Digital Intelligence, customers from various sectors, including aviation, leisure and hospitality, education, and e-commerce and retail, share their growth and success stories achieved together with Alibaba Cloud. “It is our utmost pleasure to see our customers experience a seamless transition into more digitalised operations,” said Selina Yuan, President for International Business, A
BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer18.9.2020 00:05:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the first reported data from RATIONALE 304, the Phase 3 trial of its anti-PD-1 antibody tislelizumab in combination with chemotherapy as a potential first-line treatment for patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC), and the first reported data from the pivotal Phase 2 trial of its investigational PARP inhibitor pamiparib in advanced ovarian cancer (OC) at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which takes place on September 19-21. “We are pleased to share the promising RATIONALE 304 results, which were used to support our recently accepted supplemental new drug application in first-line non-squamous NSCLC in China,” commented Yong (Ben) Ben, M.D., Chief Medical Officer, Immuno-Oncology at BeiGene. “BeiGene is evaluating tislelizuma
Sensorion Launches a Capital Increase by Means of an Accelerated Bookbuild Offering17.9.2020 19:33:00 CEST | Press release
Regulatory News: Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This press release is not intended as an offer and is for informational purpose only Sensorion (FR0012596468 – ALSEN – the “Company”) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, intends to issue new ordinary shares of a nominal value of €0.10 (the “New Shares”) for a total capital increase of approximately €30 million (US$35 million), by means of an accelerated bookbuild offering to the benefit of categories of persons (the “ReservedOffering”). The New Shares will be issued through a share capital increase without shareholders’ preferential subscription rights pursuant to the 12th resolution of the extraordinary general meeting of shareholders of the Company held on May 20, 2020 and in accordance with Article